Presbyopia Pipeline Analysis: Emerging Therapies Continue to Transform Clinical Landscape of Presbyopia
March 10, 2021 20:30 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, March 10, 2021 (GLOBE NEWSWIRE) -- Presbyopia Pipeline Analysis: Emerging Therapies Continue to Transform Clinical Landscape of Presbyopia Presbyopia pipeline majorly includes...
Age-related Macular Degeneration Pipeline Analysis of 70+ Key Companies and 70+ Key Therapeutic Products
March 09, 2021 20:20 ET
|
DelveInsight Business Research LLP
Los Angeles, USA , March 09, 2021 (GLOBE NEWSWIRE) -- Age-related Macular Degeneration Pipeline Analysis of 70+ Key Companies and 70+ Key Therapeutic Products DelveInsight anticipates the launch...
US FDA approves updated Novartis Beovu® label, to include additional safety information
June 11, 2020 01:15 ET
|
Novartis International AG
Novartis worked with US Food and Drug Administration (FDA) to update Beovu (brolucizumab) prescribing information to guide healthcare professionals in their treatment of wet AMD patients1 The...